Join Cedars-Sinai, A*STAR, ClavystBio, and Enterprise Singapore for an exclusive event hosted at co11ab Novena, bringing together global leaders in healthcare, research and innovation. Through a series of intimate fireside chats, executive leadership from Cedars-Sinai will share their insights into the financial strategies, research advancements, and translational pathways that have fueled their success in translational research, startup innovation and supporting startups to successfully scale to an exit.

Programme Overview

2:30PM - 3:00PM : Registration

3:00PM - 3:10PM: Welcome Remarks by A/Prof Yen Choo (Executive Director of co11ab) and Dr. Nirdesh Gupta (Managing Partner of Cedars-Sinai Technology Ventures ; CEO of Coronet Ventures Singapore)

3.10PM - 4:00PM: Fireside Chat #1- Clinical Intuition, Entrepreneurial Execution: Lessons in Disruptive Innovation

Dr. Clive Svendsen (Executive Director, Regenerative Medicine Institute of Cedars-Sinai)
Dr. Dermot McGovern (Director, Precision Health and Translational Medicine of Cedars-Sinai)
Khoo Shih (CEO of ClavystBio)

4:00: 4:50PM: Fireside Chat #2 - Research to Revenue: Leadership Insights into Building Serial Breakthroughs

David Wrigley (Executive Vice President and Chief Financial Officer of Cedars-Sinai)
Dr. Jeffrey Golden (Executive Vice Dean, Research and Education of Cedars-Sinai)
Irene Chong (Assistant Chief Executive, Innovation & Enterprise, A*STAR)

5.00PM - 6:30PM: Networking Session

*By registering the event, you agree and consent to receive marketing communications about events, workshops and other initiatives by co11ab

Inside the Engine:How Cedars-Sinai Powers Healthcare Innovation (US+Beyond)